Promega and QuantumCyte sign co-marketing agreement, presented joint poster at AMP 2024 Meeting
Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions
Aims to streamline clinical lab workflows with integrated tissue enrichment and nucleic acid purification solutions
New laboratory operating system revealed at the 2024 AMP Conference in Vancouver, Canada
Glox Therapeutics, involved in the development of precision antibiotic therapies based on naturally occurring bacteriocins, announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment
Find out how CLINICAL24 supporter, the IBMS, has been addressing challenges for biomedical scientists through training, education, and advocacy for over 100 years
This collaboration brings new possibilities for consistent, high-purity cfDNA isolation
Sapio Sciences, the science-aware™ lab informatics platform, has entered a co-marketing agreement with Waters Corporation to enhance data integrity, workflow efficiency, and laboratory productivity
This new development will allow mRNA therapies to be manufactured in Poland for drug developers to treat COVID, potential forms of cancer, and more
Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions
New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices
New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb
Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories
inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).
nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics
ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics
Roche’s Elecsys Amyloid Plasma Panel shows high accuracy in ruling out Alzheimer's, offering new hope for early and less invasive diagnostics
Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more
QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions
Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs
With fewer side effects than traditional therapies, this innovative treatment could redefine care for patients facing limited options
Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer
Learn more about the PathPresenter and Paige collaboration at an exclusive preconference workshop on November 3 at Pathology Visions 2024 conference